147 related articles for article (PubMed ID: 26118980)
21. Immunohistochemical analysis of retinoblastoma cell phenotype using neuronal and glial cell markers.
Orellana ME; Belfort R; Antecka E; Burnier MN
Arq Bras Oftalmol; 2016; 79(6):395-399. PubMed ID: 28076568
[TBL] [Abstract][Full Text] [Related]
22. Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA.
Laurent VE; Sampor C; Solernou V; Rossi J; Gabri M; Eandi-Eberle S; de Davila MT; Alonso DF; Chantada GL
Eur J Cancer; 2013 Sep; 49(13):2892-9. PubMed ID: 23721779
[TBL] [Abstract][Full Text] [Related]
23. MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
Sun Z; Zhang A; Jiang T; Du Z; Che C; Wang F
Int J Clin Exp Pathol; 2015; 8(11):14521-7. PubMed ID: 26823772
[TBL] [Abstract][Full Text] [Related]
24. Expression of C-kit in retinoblastoma: a potential therapeutic target.
Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
[TBL] [Abstract][Full Text] [Related]
25. High expression of TAZ indicates a poor prognosis in retinoblastoma.
Zhang Y; Xue C; Cui H; Huang Z
Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
[TBL] [Abstract][Full Text] [Related]
26. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma.
Sudhakar J; Khetan V; Madhusudan S; Krishnakumar S
Br J Ophthalmol; 2014 Mar; 98(3):402-7. PubMed ID: 24385289
[TBL] [Abstract][Full Text] [Related]
28. Role of High-mobility Group Protein A Isoforms and Their Clinicopathologic Significance in Primary Retinoblastoma.
Singh MK; Singh L; Sen S; Pushker N; Sharma A; Ahamad FC; Chawla B; Kashyap S
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):244-250. PubMed ID: 26657872
[TBL] [Abstract][Full Text] [Related]
29. [Study on the risk factors for optic nerve invasion in 381 cases of retinoblastoma].
Ren RJ; Li B; Li LQ; Sun XL
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):489-92. PubMed ID: 17897523
[TBL] [Abstract][Full Text] [Related]
30. Association of rs11801299 and rs1380576 polymorphisms at MDM4 with risk, clinicopathological features and prognosis in patients with retinoblastoma.
Yu F; Jiang Z; Song A
Cancer Epidemiol; 2019 Feb; 58():153-159. PubMed ID: 30597480
[TBL] [Abstract][Full Text] [Related]
31. TREFOIL FACTOR FAMILY 1 EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN PATIENTS WITH RETINOBLASTOMA.
Busch M; Metz K; Beier M; Biewald E; Dünker N
Retina; 2018 Dec; 38(12):2422-2428. PubMed ID: 29016460
[TBL] [Abstract][Full Text] [Related]
32. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
33. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins.
Wagner N; Wagner KD; Sefton M; Rodríguez-Tébar A; Grantyn R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1932-9. PubMed ID: 10845619
[TBL] [Abstract][Full Text] [Related]
34. CDKN1C (p57KIP2) mRNA expression in human retinoblastomas.
Madhavan J; Mallikarjuna K; Vikas K; George R; Bremner R; Kumaramanickavel G
Ophthalmic Genet; 2010 Sep; 31(3):141-6. PubMed ID: 20565244
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetics and cytology of retinoblastomas.
Bártová E; Kozubek S; Gajová H; Jirsová P; Zlúvová J; Taslerová R; Koutná I; Kozubek M
J Cancer Res Clin Oncol; 2003 Feb; 129(2):89-99. PubMed ID: 12669233
[TBL] [Abstract][Full Text] [Related]
37. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
38. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of Fas expression in retinoblastoma.
Shanmugam MP; Lakshmi A; Biswas J; Krishnakumar S
Ocul Immunol Inflamm; 2003 Jun; 11(2):107-13. PubMed ID: 14533029
[TBL] [Abstract][Full Text] [Related]
40. [Expressions and clinical significance of high mobility group box-1 mRNA and protein in laryngeal squamous cell carcinoma tissues and serum].
Guo Y; Liu Y; Tan PQ; Li G; Su ZW; Tian YQ; Qiu YZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):487-90. PubMed ID: 22932142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]